Oncolytics Biotech Inc.
ONCY
$0.81
-$0.03-3.57%
NASDAQ
Corporate Info
Website
Phone Number
403 670 7377
Address
4350 Executive Drive
Suite 325
San Diego, CA 92121
Suite 325
San Diego, CA 92121
Country
United States
Year Founded
1998
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
29
Business Description
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in San Diego, California.